by In2Pharma | Feb 16, 2022 | News
The Netherlands On 1 January 2022, a new provision will be added to the chapter in the GMH* Code regarding transparency. This provision relates to the clarifying note that the GMH foundation publishes annually at the time of publication of the reports by the...